Phase I trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients
| Image |  |
|---|---|
| Description | scientific article published on 04 December 2020 |
| Author/s |
author: N. Harry Hendrikse |
| Publication date | December 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |